1-3 of 3
Geneviève Favre
Close
Sort by
Journal Articles

Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)

Alexandra Schifferli, Axel Rüfer, Alicia Rovo, Nathan Cantoni, Andreas Holbro, Geneviève Favre, Heike Faeth, Renata Rosa Pereira, Anna Wieland, Jan Dirks, Falk Nimmerjahn, Thomas Kuehne
Journal: Blood
Blood (2021) 138 (Supplement 1): 3149.
https://doi.org/10.1182/blood-2021-146648
Published: 2021
Journal Articles

Effects of the Sympathicomimetic Agonist Mirabegron on Disease Course, Mutant Allele Burden, Marrow Fibrosis, and Nestin Positive Stem Cell Niche in Patients with JAK2 -Mutated Myeloproliferative Neoplasms. a Prospective Multicenter Phase II Trial SAKK 33/14

Beatrice Drexler, MD, Jakob Passweg, MD, Martin Bigler, Alexandre PA Theocharides, MD, Nathan Cantoni, MD, Peter Keller, MD, Georg Stuessi, MD, Axel Rüfer, MD, Rudolf A. Benz, MD, Geneviève Favre, MD, Alexandar Tzankov, MD, Pontus Lundberg, PhD, Andrea Fuhrer, PhD, Christine Biaggi, Markus G Manz, MD, Mario Bargetzi, MD, Simon Mendez-Ferrer, PhD, Radek C. Skoda, MD
Journal: Blood
Blood (2016) 128 (22): 3108.
https://doi.org/10.1182/blood.V128.22.3108.3108
Published: 2016
Journal Articles

Severe Adverse Events of Allogeneic Related Peripheral Blood Stem Cell Donors -Results of Nation-Wide 3,262 Consecutively and Prospectively Registered Case-Survey in Japan and of Its Comparison to the Outcome of Retrospective Survey Shared with EBMT for Stem Cell Donors.

Yoshihisa Kodera, MD, Shunichi Kato, MD, Mine Harada, MD, Shintaro Shiobara, MD, Nobuyuki Hamajima, MD, Yasuo Morishima, MD, Mitsune Tanimoto, MD, Shigetaka Asano, MD, Yasuo Ikeda, MD, Hiroo Dohi, MD, Tatsutoshi Nakahata, MD, Masahiro Imamura, MD, Keisei Kawa, MD, Yoichi Takaue, MD, Yoshinobu Kanda, MD, Kazuhito Yamamoto, MD, Genevieve Favre, MD, Alois Gratwohl, MD
Journal: Blood
Blood (2005) 106 (11): 1119.
https://doi.org/10.1182/blood.V106.11.1119.1119
Published: 2005